OpenAI acquires drug development platform Orchestra Bio, expands life sciences push

OpenAI has acquired Orchestra Bio, a platform that helps biopharmaceutical companies coordinate drug development, as it looks to combine its artificial intelligence (AI) models…

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.aninews.in)